Using a commercial array followed by confirmatory qRT-PCR analysis, we found an overall increase in CCNE1, CTGF, and Cyr61 expression in tumor samples compared to control when grouping all HCC samples. This evidence concerns the gene CCN2 and hepatocellular carcinoma.